Sultiame once per day in obstructive sleep apnoea (FLOW): a multicentre, randomised, double-blind, placebo-controlled, dose-finding, phase 2 trial

Journal:

The Lancet

Published:

2025-10-10

DOI:

10.1016/s0140-6736(25)01196-1

Affiliations:

10

Authors:

36

Go to article

Institutions	Authors	Share
Desitin Arzneimittel GmbH, Germany	2.000000	0.18
Sahlgrenska Academy, GU, Sweden	2.000000	0.18
non-affiliated author contributions, Germany	1.000000	0.09
Sahlgrenska University Hospital (SU), GU, Sweden	1.000000	0.09
Städtisches Klinikum Karlsruhe gGmbH, Germany	1.000000	0.09
Krankenhaus Bethanien gGmbH, Germany	1.000000	0.09
Anima Research Center, Belgium	1.000000	0.09
Charité - University Medicine Berlin, Germany	1.000000	0.09
Hospital Quiron Teknon, BMA, Spain	1.000000	0.09

Interested in Cardiovascular Medicine and Haematology?